Plateletworks: A screening assay for clopidogrel therapy monitoring in healthy cats

Department of Clinical Sciences, Faculty of Veterinary Medicine, Université de Montréal, Québec, Canada.
Canadian journal of veterinary research = Revue canadienne de recherche vétérinaire (Impact Factor: 1.02). 01/2009; 73(1):73-6.
Source: PubMed


Plateletworks is a screening assay used in human medicine to monitor platelet-inhibiting drugs. As arterial thromboembolism is a common complication in cats suffering from cardiomyopathy, they are often treated with anti-platelet medication. Clopidogrel (Plavix), an anti-platelet aggregation drug, has recently been evaluated in healthy cats. The purpose of this study was to determine if the Plateletworks method can detect a decrease in platelet aggregation in cats receiving clopidogrel. Nine healthy adult cats were used for this study. Platelet aggregation was measured before and after a 3-day clopidogrel treatment (18.75 mg SID). Platelet aggregation after the clopidogrel treatment was significantly lower (P < 0.01). The Plateletworks method appears to be a promising test to monitor clopidogrel therapy in cats.

Download full-text


Available from: Christian Bedard, Aug 13, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Arterial thromboembolism is a rare disease in cats with an estimated prevalence of less than 0.57%. The outcome is often disastrous. The most commonly identified underlying cause is a form of cardiomyopathy. Thromboemboli usually tend to lodge near the aorta trifurcation, causing extreme pain, paralysis of the rear limbs, no palpable pulse wave, and cold rear limbs. Treatment is aimed at palliation, thrombolysis, and prevention of recurrence of thrombus formation. The prognosis is usually guarded and medical treatment tends not to influence the outcome markedly. In this review, we describe the pathophysiology, common clinical features, diagnostics, and treatment of arterial thromboembolism in cats. We also summarize risk factors and new developments in prevention and treatment.
    No preview · Article · Dec 2009 · Tijdschrift voor diergeneeskunde
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tests that evaluate many aspects of platelet function have been applied in both human and veterinary medicine for the monitoring of treatment with platelet function inhibitors and for detection of platelet function abnormalities (inherited or acquired). Interspecies variation in the response to various platelet agonists is an important consideration when methods that have been developed for people are applied in other species. At the present time, many of these assays are not readily available in standard veterinary practice. Advanced platelet function testing for veterinary patients is offered at select academic institutions. Discussion with a specialist is recommended when considering the use of these tests, and the relative strengths and limitations of each assay should be considered in the interpretation of test results.
    No preview · Article · Jan 2012 · Veterinary Clinics of North America Small Animal Practice
  • [Show abstract] [Hide abstract]
    ABSTRACT: To review the mechanisms of platelet activation and options for diagnosing and treating platelet hyperactivity in relation to thrombosis in dogs and cats. Prospective, retrospective, and review articles, as well as textbook chapters in both human and veterinary medicine. Articles were primarily, but not exclusively, retrieved via Medline. In people, platelets are known to play a key role in the development of arterial thrombosis in numerous disease states and antiplatelet drugs are the cornerstone in the treatment of acute events and for prevention in patients at risk. For many years, aspirin was used as the sole antiplatelet drug in people, but the introduction of adenosine diphosphate receptor antagonists and integrin α(IIb) β(3) inhibitors has significantly improved outcome in selective groups of patients. The understanding of platelet activation in disease states has increased dramatically over the past decade. Simultaneously, a host of new methods for evaluating platelet function have been developed, which enable primarily researchers, but also clinicians to monitor the activity of platelets. Many of these methods have been validated for research purposes, but few have found their way to the clinics. Not a single correctly randomized clinical trial has been carried out with any antiplatelet drug for any indication in dogs or cats, and consequently, treatment is empiric and largely based on expert opinion or data from experimental studies. The pathogenesis of thromboembolic disease is complex and multifactorial and the role of hyperactive platelets in this etiology remains to be clarified in most of the diseases associated with thrombosis in dogs and cats. Until efficacy data from well-designed studies are available, antithrombotic therapy should consist of close monitoring, good supportive care, and judicious empirical use of antiplatelet agents.
    No preview · Article · Feb 2012
Show more